Patents Assigned to Jiangsu Ascentage Biomed Development Inc.
  • Patent number: 11298339
    Abstract: Disclosed are a bisdiazabicyclo compound for treating and/or preventing hepatitis virus-related diseases or disorders, a method for treating and/or preventing hepatitis virus-related diseases or disorders by using the bisdiazabicyclo compound, and a use of the bisdiazabicyclo compound in the preparation of a drug for treating and/or preventing hepatitis virus-related diseases or disorders, and/or eliminating or mitigating hepatitis virus-related diseases or disorders.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: April 12, 2022
    Assignees: JIANGSU ASCENTAGE BIOMED DEVELOPMENT INC., HEALTHQUEST PHARMA INC.
    Inventors: Yifan Zhai, Xiaoyong Zhang, Jinlin Hou, Dajun Yang
  • Patent number: 9783539
    Abstract: Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their uses as ALK inhibitors.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: October 10, 2017
    Assignee: Jiangsu Ascentage Biomed Development Inc.
    Inventors: Jianyong Chen, Yunlong Zhou, Shaomeng Wang, Ming Guo, Dajun Yang, Lingling Jiao, Yu Jing, Xu Qian, Liu Liu, Longchuan Bai, Chao-Yie Yang, Donna McEachern
  • Publication number: 20170066761
    Abstract: Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their uses as ALK inhibitors
    Type: Application
    Filed: February 27, 2014
    Publication date: March 9, 2017
    Applicant: Jiangsu Ascentage Biomed Development Inc.
    Inventors: Jianyong CHEN, Yunlong ZHOU, Shaomeng WANG, Ming GUO, Dajun YANG, Lingling JIAO, Yu JING, Xu QIAN, Liu LIU, Longchuan BAI, Chao-Yie YANG, Donna MCEACHERN